Suez's share in Prodeval supports commercial deployment of Valopur
Publication date: December 2016 Source:Membrane Technology, Volume 2016, Issue 12 Suez Ventures, The Suez Venture Capital Fund, has acquired a 22% minority share in Prodeval of Châteauneuf-sur-Isère, France, in a move that supports the commercial deployment of the French company's Valopur product in the high-growth biomethane market – both in France and worldwide. (Source: Membrane Technology)
Source: Membrane Technology - December 19, 2016 Category: Materials Science Source Type: research
Michael Rosenblatt
Nature Reviews Drug Discovery 15, 672 (2016).
doi:10.1038/nrd.2016.203
Although biopharma start-up companies have to be laser-focused on translational science, this single-mindedness sometimes comes at the expense of clinical development expertise. The venture capital group Flagship Ventures has now named Michael Rosenblatt as Chief Medical Officer to help its portfolio of companies fill that experience gap. Rosenblatt was Chief Medical Officer at Merck & Co. for 7 years prior to this role, and Dean of Tufts University School of Medicine before that. He talks with Asher Mullard about his new job, and his novel ...
Source: Nature Reviews Drug Discovery - September 28, 2016 Category: Drugs & Pharmacology Tags: News and Analysis Source Type: research
No bounceback for biotech in 2016
Stocks, public offerings, venture capital, and M&A on the skids (Source: Chemical and Engineering News)
Source: Chemical and Engineering News - September 5, 2016 Category: Chemistry Authors: Rick Mullin Source Type: research
Research on Evaluation of Venture Capital Fund Project Based on Data Envelopment Analysis Model
(Source: Journal of Computational and Theoretical Nanoscience)
Source: Journal of Computational and Theoretical Nanoscience - June 16, 2016 Category: Nanotechnology Authors: Yuanjun, ZhaoZengrui, Tian Source Type: research
Entrepreneurial patent management in pharmaceutical startups.
This article aims to explore patent management in pharmaceutical startups. The results show that startups need to deal with several challenges related to patenting and a more 'entrepreneurial' approach to patent management is called for. Resource constraints, venture capital provision, exits and other conditions and events must be readily considered in the patent management process to build a successful pharmaceutical venture, something that could benefit the pharmaceutical industry as a whole.
PMID: 26948802 [PubMed - as supplied by publisher] (Source: Drug Discovery Today)
Source: Drug Discovery Today - March 3, 2016 Category: Drugs & Pharmacology Authors: Holgersson M, Phan T, Hedner T Tags: Drug Discov Today Source Type: research
Government policies towards Israel's high-tech powerhouse
In this study the analyses, carried out through the lens of cluster and national innovation system (NIS), have shown that the thriving high-tech clusters are the result of government-led policies in creating the venture capital (VC) industry with the impacts of Yozma program. Importantly, the government financing did not crowd out but crowd in private investments. Israel presents an interesting case of the most successful Silicon Valley-style economy. The lessons of Israel in successfully climbing the technological ladder to become a high-tech powerhouse would be useful for other countries to learn how to promote high-tech...
Source: Technovation - February 24, 2016 Category: Science Source Type: research
AimBrain raises funding for behaviour based biometrics
Publication date: January 2016 Source:Biometric Technology Today, Volume 2016, Issue 1 Scottish security start-up AimBrain has raised £350,000 from Episode1, the venture capital firm behind Zoopla, LoveFilm and BetFair, to boost its behavioural biometrics, reports The Telegraph. (Source: Biometric Technology Today)
Source: Biometric Technology Today - January 26, 2016 Category: Information Technology Source Type: research
Incentives for Starting Small Companies Focused on Rare and Neglected Diseases
Abstract
Starting biotech or pharmaceutical companies is traditionally thought to be based around a scientist, their technology platform or a clinical candidate spun out from another company. Between us we have taken a different approach and formed two small early stage companies after initially leveraging the perspective of a parent with a child with a life-threatening rare disease. Phoenix Nest (http://www.phoenixnestbiotech.com/) was co-founded to work on treatments for Sanfilippo syndrome a devastating neurodegenerative lysosomal storage disorder. In the space of just over 3 years we have built up co...
Source: Pharmaceutical Research - December 14, 2015 Category: Drugs & Pharmacology Source Type: research
Exploring strategic venture capital financing with Silicon Valley style
Publication date: January 2016 Source:Technological Forecasting and Social Change, Volume 102 Author(s): Jarunee Wonglimpiyarat The study explores Israel's Silicon Valley style of entrepreneurial financing and venture capital (VC) management. Israel is known as the most successful Silicon Valley-style economy, similar to the US Silicon Valley. The high-tech economy of Israel presents an interesting case of effective institutional setting and policies that transform the country into the innovation nation. The analyses were carried out based on the competitive Diamond model. The results have shown that the thriving Isr...
Source: Technological Forecasting and Social Change - December 13, 2015 Category: Science Source Type: research
Health care providers under pressure: making the most of challenging times.
Authors: Davis SB, Robinson PJ
Abstract
Whether the slowing economic recovery, tight credit markets, increasing costs, or the uncertainty surrounding health care reform, the health care industry faces some sizeable challenges. These factors have put considerable strain on the industry's traditional financing options that the industry has relied on in the past--bonds, banks, finance companies, private equity, venture capital, real estate investment trusts, private philanthropy, and grants. At the same time, providers are dealing with rising costs, lower reimbursement rates, shrinking demand for elective pro...
Source: Journal of Health Care Finance - December 2, 2015 Category: Health Management Tags: J Health Care Finance Source Type: research
Business Angel Investments: Risks and Opportunities
Publication date: 20 October 2015 Source:Procedia - Social and Behavioral Sciences, Volume 207 Author(s): Alina Dibrova For the last few years the need of improving the access to finance for the companies, especially SME's (small and middle enterprises), has been on the agenda in European Union. As long as the traditional financing such as bank loans became more complex to attract, the development of alternative investment, like seed and start-up capital investments, crowd funding, venture capital and Business angels, became a bold topic. Moreover, there is an opinion that development of alternative investment might ...
Source: Procedia Social and Behavioral Sciences - November 26, 2015 Category: Psychiatry & Psychology Source Type: research
Patents, trademarks, and their complementarity in venture capital funding
Publication date: Available online 25 November 2015 Source:Technovation Author(s): Haibo Zhou, Philipp G. Sandner, Simon Luca Martinelli, Joern H. Block This paper analyzes the effects of patents and trademarks in the financing of start-ups through venture capitalists (VCs). Patents and trademarks signal a start-up's technological and marketing capabilities. We find that patents and trademarks not only have direct effects on venture capital financing but also have complementary effects. Start-ups that apply for both patents and trademarks yield higher VC funding than do those firms that apply for only one of th...
Source: Technovation - November 25, 2015 Category: Science Source Type: research
Firms Get Funding From Breakout Labs
Venture Capital: Chemistry-based start-ups find support to overcome early R&D and business hurdles (Source: Chemical and Engineering News)
Source: Chemical and Engineering News - October 6, 2015 Category: Chemistry Authors: Ann M. Thayer Source Type: research
Start-up Clear Labs Plans To Sequence The Food Supply
New company raises $6.5 million in venture capital funding (Source: Chemical and Engineering News)
Source: Chemical and Engineering News - September 16, 2015 Category: Chemistry Authors: Melody Bomgartner Source Type: research
Radioprotectors and Radiomitigators for Improving Radiation Therapy: The Small Business Innovation Research (SBIR) Gateway for Accelerating Clinical Translation.
Abstract
Although radiation therapy is an important cancer treatment modality, patients may experience adverse effects. The use of a radiation-effect modulator may help improve the outcome and health-related quality of life (HRQOL) of patients undergoing radiation therapy either by enhancing tumor cell killing or by protecting normal tissues. Historically, the successful translation of radiation-effect modulators to the clinic has been hindered due to the lack of focused collaboration between academia, pharmaceutical companies and the clinic, along with limited availability of support for such ventures. Th...
Source: Radiation Research - August 18, 2015 Category: Physics Authors: Prasanna PG, Narayanan D, Hallett K, Bernhard EJ, Ahmed MM, Evans G, Vikram B, Weingarten M, Coleman CN Tags: Radiat Res Source Type: research
